Modeling of HLA class II susceptibility to Type I diabetes reveals an effect associated with DPB1
Article first published online: 12 OCT 2001
Copyright © 2001 Wiley-Liss, Inc.
Volume 21, Issue 3, pages 212–223, November 2001
How to Cite
Valdes, A. M., Noble, J. A., Génin, E., Clerget-Darpoux, F., Erlich, H. A. and Thomson, G. (2001), Modeling of HLA class II susceptibility to Type I diabetes reveals an effect associated with DPB1. Genet. Epidemiol., 21: 212–223. doi: 10.1002/gepi.1030
- Issue published online: 12 OCT 2001
- Article first published online: 12 OCT 2001
- Manuscript Accepted: 17 JAN 2001
- Manuscript Received: 14 JUN 2000
- National Institutes of Health. Grant Numbers: GM56688 (A.M.V., E.G., G.T.), DK46626 (J.A.N., H.A.E)
- affected sib pairs;
- Human Biological Data Interchange;
- marker association segregation chi-square method
In this report, we present evidence that the HLA class II DPB1 locus (or a locus with alleles in linkage disequilibrium with DPB1) contributes to Type I diabetes (IDDM) susceptibility in addition to the contribution of the HLA DR and DQ loci. The marker association segregation chi-square (MASC) method, which fits both genotype frequency and affected sib-pair identity-by-descent (IBD) distributions, was applied to 257 sib pairs affected with IDDM. Fitting DR-DQ as the sole HLA susceptibility loci was strongly rejected. Next, we considered the DPB1 contribution to disease susceptibility. Published reports indicate a predisposing role for alleles DPB1*0301 and DPB1*0202, including our previous stratification analyses of association data on this sample. IDDM probands were stratified into those not carrying the alleles DPB1*0301 and DPB1*0202 (group DPB1-A), and those carrying at least one copy of either allele (group DPB1-B). Both groups of probands have almost identical frequencies of DR and DQ haplotypes but significantly different IBD distributions in the subset of families with probands who do not carry the highly predisposing DR3/DR4 genotype. In these data, DPB1 (or a locus in linkage disequilibrium), in addition to DR-DQ, is involved in IDDM susceptibility and affects IBD in the HLA region. Addition of DPB1 in a genetic model of IDDM gives a better fit to the data than consideration of DR-DQ alone. Our results are consistent with previous reports implicating DPB1 in IDDM susceptibility. Genet. Epidemiol. 21:212–223, 2001. © 2001 Wiley-Liss, Inc.